- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02343146
Healthy Eating, Physical Activity, and Glycemic Control in Young Children With T1D
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Young children (<5 years) comprise a growing number of persons diagnosed with type 1 diabetes (T1D)--a costly, chronic illness [1, 2]. Early age at diagnosis and poor glycemic control during these early years increases risk for development of serious diabetes-related complications (ref). Thus, these years represent a critical period for establishing proper patterns of T1D management and glycemic control in young children [7]. In addition to young children's daily reliance on parents for T1D care, such as blood glucose (BG) monitoring and insulin administration, careful attention must be paid to diet and physical activity regulation. Behavioral interventions supporting and enhancing T1D management among parents of these young children have the potential for significant impact on children's glycemic control as well as developmentally important outcomes, and may reduce both immediate and long-term clinical and public health burdens of T1D complications.
Although multicomponent behavioral interventions for parents of young children with T1D demonstrate potentially promising psychosocial outcomes [8-10], concomitant improvements in children's glycemic control from these interventions remain elusive. Two critical areas not yet addressed directly in interventions is the promotion of healthy eating and engagement in consistent physical activity in young children, nor the behavioral strategies to support parents in these challenges that occur multiple times daily (e.g., each meal/snack, each physical activity experience). The current proposal utilizes the extensive expertise of our multidisciplinary team to refine and pilot an innovative and translatable intervention targeting eating and physical activity behaviors directly associated with glycemic control in young children that can ultimately be adopted outside of research settings. The investigators' prior successful clinical research efforts engaging parents of young children with T1D in behavioral interventions (R01 DK080102) places them in a unique position to further design and pilot this intervention and ultimately be well poised to run a future full-scale efficacy trial.
The current proposal shifts the investigators' prior interventions' focus away from parental stress and instead highlights behavioral strategies promoting healthy eating and engagement in consistent physical activity, as well as nutrition and physical activity links to glycemic control. Based upon positive preliminary data the investigators will utilize novel assessment (accelerometry, personal activity monitors (PAM), and continuous glucose monitors (CGM)) and intervention components (parent consultants and trained intervention telephone counselors), with the intervention being delivered via telephone and in-person. The investigators will follow an iterative mixed methods approach to refine the intervention from Phase 1 to Phase 2. During phase 1 the investigators will pre-pilot the intervention by examining feasibility and acceptability in 10 parents (of children ages 1-5 yrs with a minimum of 1 yr duration of diabetes). The investigators will use qualitative interviews, questionnaire, and objective (CGM, accelerometry) data to help refine key intervention components and discern best areas for intervention target (i.e., low glycemic breakfast or different meal; planned physical activity or increasing steps through daily living; PAM or accelerometry). This phase will include soliciting feedback from the advisory board leading to further refinement of the intervention and manual of procedures. During phase 2 the investigators will execute a pilot randomized trial evaluating whether glycemic control and developmentally-important outcomes (child feeding and physical activity) in young children with T1D can be favorably impacted. Phase 2 will include 60 parents (of children ages 1-5 yrs) randomly allocated to either the intervention (n=30) or standard care (n=30). Assessments will be completed 3 times (T1, T2-immediately post intervention, and T3-6 months post-intervention). Clinical, biological, and behavioral diabetes outcomes will be measured. Specific Aims for this trial are:
Aim 1. Pilot test and refine innovative and feasible assessment and intervention components for T1D control in young children, and examine acceptability and impact in parents of young children. At the conclusion of Phase 1, this Aim results in an innovative intervention program, supported by state of the art assessment tools and preliminary data. The investigators hypothesize that the intervention will be associated with high feasibility and acceptability, improved T1D management, and reduction of behavioral challenges related to eating and physical activity.
Aim 2. Determine the intervention's efficacy for improving young children's glycemic control and parent's management of eating and physical activity behaviors. The investigators hypothesize that the Phase 2 pilot will demonstrate that relative to usual care, the intervention will evidence 1) Significantly better glycemic control (i.e., HbA1c <8.5% and higher percentage of BG levels in the 100-200 mg/dl range, per ADA recommendations) and 2) Significantly fewer child feeding and activity behavior problems (e.g., food refusal, dawdling at mealtimes, physical inactivity). 3. Mediating effects of eating and physical activity on glycemic control will also be explored.
Aim 3. Explore the feasibility of program implementation in a larger scale efficacy trial, and in clinical T1D management. Using a purposeful sample subset of parents in the intervention condition, the investigators will use qualitative interviews to further examine the impact of the intervention, and assist in further refinement prior to a larger scale trial. The investigators will also interview advisory board members including members of the health care team to gather system- and provider-level data about key capacities to inform the integration of our intervention into patient/work flow in anticipation of a larger efficacy trial.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
District of Columbia
-
Washington, District of Columbia, Verenigde Staten, 20010
- Children's Research Institute
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- parent of a child age 1-5 and their target child (children are considered secondary participants)
- child with a minimum of 1 year duration of T1D
- parents must have ready and consistent access to a mobile telephone with text messaging capability
Exclusion Criteria:
- Parent participants cannot have serious mental illness or developmental disability that would limit participation
- Child participants cannot have other life-threatening disease (e.g., cancer, cystic fibrosis) or developmental disability (e.g., autism, mental retardation)
- Parent participants must be able to adequately understand, speak, and read English
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Type One Training (TOT)
The intervention group will receive the proposed intervention composed of peer parent consultants, telephone and in-person sessions with a trained interventionist, and SMS text messaging aimed at improving child glycemic control through improved nutrition and physical activity.
|
The intervention is comprised of a number of modes of delivery including in person, use of parent peer consultant, telephone intervention, and text messaging.
The intervention is based on Social Cognitive Theory and previous work of the investigators.The focus of the intervention is on working with parents to improve child eating and physical activity behaviors as a means of improving glycemic control in very young children with type 1 diabetes.
|
|
Geen tussenkomst: Comparison
The comparison group will receive usual care with the diabetes team.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Glycemic Control/HbA1c
Tijdsspanne: 6 months post intervention
|
Change in glycemic control from baseline to 6 months post intervention
|
6 months post intervention
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Child eating as measured by Remote Food Photography by the parent
Tijdsspanne: 6 months post intervention
|
Change in child eating behaviors from baseline to 6 months post intervention
|
6 months post intervention
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Randi Stresiand, PhD, Children's National Research Institute
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 5649
- DP3DK103998 (Subsidie/contract van de Amerikaanse NIH)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .